Literature DB >> 20858905

Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease.

Kiran Musunuru1, Wendy S Post, William Herzog, Haiqing Shen, Jeffrey R O'Connell, Patrick F McArdle, Kathleen A Ryan, Quince Gibson, Yu-Ching Cheng, Elizabeth Clearfield, Andrew D Johnson, Geoffrey Tofler, Qiong Yang, Christopher J O'Donnell, Diane M Becker, Lisa R Yanek, Lewis C Becker, Nauder Faraday, Lawrence F Bielak, Patricia A Peyser, Alan R Shuldiner, Braxton D Mitchell.   

Abstract

BACKGROUND: Genome-wide association studies have identified a locus on chromosome 9p21.3 to be strongly associated with myocardial infarction/coronary artery disease and ischemic stroke. To gain insights into the mechanisms underlying these associations, we hypothesized that single nucleotide polymorphisms (SNPs) in this region would be associated with platelet reactivity across multiple populations. METHODS AND
RESULTS: Subjects in the initial population included 1402 asymptomatic Amish adults in whom we measured platelet reactivity (n=788) and coronary artery calcification (CAC) (n=939). Platelet reactivity on agonist stimulation was measured by impedance aggregometry, and CAC was measured by electron beam CT. Twenty-nine SNPs at the 9p21.3 locus were genotyped using the Affymetrix 500K array. Twelve correlated SNPs in the locus were significantly associated with platelet reactivity (all P≤0.001). The SNP most strongly associated with platelet reactivity, rs10965219 (P=0.0002), also was associated with CAC (P=0.002) along with 9 other SNPs (all P<0.004). Association of rs10965219 with platelet reactivity persisted after adjustment for CAC, a measure of underlying atherosclerotic burden known to affect platelet reactivity. We then tested rs10965219 for association with platelet function in 2364 subjects from the Framingham Heart Study and 1169 subjects from the Genetic Study of Aspirin Responsiveness. The rs10965219 G allele (frequency ≈51% across all 3 populations) was significantly associated with higher platelet reactivity in the Framingham Heart Study (P=0.001) and trended toward higher reactivity in the Genetic Study of Aspirin Responsiveness (P=0.087); the combined P value for metaanalysis was 0.0002.
CONCLUSIONS: These results suggest that risk alleles at 9p21.3 locus may have pleiotropic effects on myocardial infarction/coronary artery disease and stroke risk, possibly through their influence on platelet reactivity.

Entities:  

Mesh:

Year:  2010        PMID: 20858905      PMCID: PMC3031788          DOI: 10.1161/CIRCGENETICS.109.923508

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  42 in total

1.  Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21.

Authors:  Mar Matarin; W Mark Brown; Andrew Singleton; John A Hardy; James F Meschia
Journal:  Stroke       Date:  2008-03-13       Impact factor: 7.914

2.  Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study.

Authors:  Shu Ye; Johann Willeit; Florian Kronenberg; Qingbo Xu; Stefan Kiechl
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

3.  Four SNPS on chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian population (GeneQuest).

Authors:  K G Abdullah; L Li; G-Q Shen; Y Hu; Y Yang; K G MacKinlay; E J Topol; Q K Wang
Journal:  Ann Hum Genet       Date:  2008-05-26       Impact factor: 1.670

4.  The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study.

Authors:  Braxton D Mitchell; Patrick F McArdle; Haiqing Shen; Evadnie Rampersaud; Toni I Pollin; Lawrence F Bielak; Cashell Jaquish; Julie A Douglas; Marie-Hélène Roy-Gagnon; Paul Sack; Rosalie Naglieri; Scott Hines; Richard B Horenstein; Yen-Pei C Chang; Wendy Post; Kathleen A Ryan; Nga Hong Brereton; Ruth E Pakyz; John Sorkin; Coleen M Damcott; Jeffrey R O'Connell; Charles Mangano; Mary Corretti; Robert Vogel; William Herzog; Matthew R Weir; Patricia A Peyser; Alan R Shuldiner
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

5.  The eukaryotic genome as an RNA machine.

Authors:  Paulo P Amaral; Marcel E Dinger; Tim R Mercer; John S Mattick
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

6.  Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.

Authors:  Themistocles L Assimes; Joshua W Knowles; Analabha Basu; Carlos Iribarren; Audrey Southwick; Hua Tang; Devin Absher; Jun Li; Joan M Fair; Geoffrey D Rubin; Stephen Sidney; Stephen P Fortmann; Alan S Go; Mark A Hlatky; Richard M Myers; Neil Risch; Thomas Quertermous
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

7.  Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.

Authors:  Heribert Schunkert; Anika Götz; Peter Braund; Ralph McGinnis; David-Alexandre Tregouet; Massimo Mangino; Patrick Linsel-Nitschke; Francois Cambien; Christian Hengstenberg; Klaus Stark; Stefan Blankenberg; Laurence Tiret; Pierre Ducimetiere; Andrew Keniry; Mohammed J R Ghori; Stefan Schreiber; Nour Eddine El Mokhtari; Alistair S Hall; Richard J Dixon; Alison H Goodall; Henrike Liptau; Helen Pollard; Daniel F Schwarz; Ludwig A Hothorn; H-Erich Wichmann; Inke R König; Marcus Fischer; Christa Meisinger; Willem Ouwehand; Panos Deloukas; John R Thompson; Jeanette Erdmann; Andreas Ziegler; Nilesh J Samani
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

8.  Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.

Authors:  Nilesh J Samani; Olli T Raitakari; Kalle Sipilä; Martin D Tobin; Heribert Schunkert; Markus Juonala; Peter S Braund; Jeanette Erdmann; Jorma Viikari; Leena Moilanen; Leena Taittonen; Antti Jula; Eero Jokinen; Tomi Laitinen; Nina Hutri-Kähönen; Markku S Nieminen; Y Antero Kesäniemi; Alistair S Hall; Janne Hulkkonen; Mika Kähönen; Terho Lehtimäki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-03       Impact factor: 8.311

9.  Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations.

Authors:  Kunihiko Hinohara; Toshiaki Nakajima; Megumi Takahashi; Shigeru Hohda; Taishi Sasaoka; Ken-Ichi Nakahara; Kouji Chida; Motoji Sawabe; Takuro Arimura; Akinori Sato; Bok-Soo Lee; Ji-Min Ban; Michio Yasunami; Jeong-Euy Park; Toru Izumi; Akinori Kimura
Journal:  J Hum Genet       Date:  2008-02-09       Impact factor: 3.172

10.  Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis.

Authors:  Arne S Schaefer; Gesa M Richter; Birte Groessner-Schreiber; Barbara Noack; Michael Nothnagel; Nour-Eddine El Mokhtari; Bruno G Loos; Søren Jepsen; Stefan Schreiber
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more
  21 in total

1.  Stroke Genetics Update: 2011.

Authors:  John W Cole; James F Meschia
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

Review 2.  Advances in genetics 2010.

Authors:  James F Meschia
Journal:  Stroke       Date:  2011-01-13       Impact factor: 7.914

3.  From Genotype to Phenotype: A Primer on the Functional Follow-up of Genome-Wide Association Studies in Cardiovascular Disease.

Authors:  Jennie Lin; Kiran Musunuru
Journal:  Circ Genom Precis Med       Date:  2018-01-30

4.  Multiple thrombophilia mutations as a possible cause of premature myocardial infarction.

Authors:  Gabriela Dostálová; Jan Bělohlávek; Zuzana Hlubocká; Kristýna Bayerová; Petra Bobčiková; Tomáš Kvasnička; Jan Kvasnička; Aleš Linhart; Debora Karetová
Journal:  Wien Klin Wochenschr       Date:  2017-04-05       Impact factor: 1.704

5.  Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.

Authors:  Andrew D Johnson; Shih-Jen Hwang; Arend Voorman; Alanna Morrison; Gina M Peloso; Yi-Hsiang Hsu; George Thanassoulis; Christopher Newton-Cheh; Ian S Rogers; Udo Hoffmann; Jane E Freedman; Caroline S Fox; Bruce M Psaty; Eric Boerwinkle; L Adrienne Cupples; Christopher J O'Donnell
Journal:  Circulation       Date:  2013-01-11       Impact factor: 29.690

6.  Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.

Authors:  Wei Wang; Seon Oh; Mark Koester; Sandra Abramowicz; Nan Wang; Alan R Tall; Carrie L Welch
Journal:  Circ Cardiovasc Genet       Date:  2016-04-20

7.  VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.

Authors:  Yibo Wang; Jinxing Chen; Yu Zhang; Lv Bin; Kai Sun; Weifeng Yu; Jibin Liu; Channa Zhang; Haiqing Shen; Zhihui Hou; Fangfang Yu; Rutai Hui
Journal:  Hum Genet       Date:  2012-08-23       Impact factor: 4.132

Review 8.  Platelet signaling.

Authors:  Timothy J Stalker; Debra K Newman; Peisong Ma; Kenneth M Wannemacher; Lawrence F Brass
Journal:  Handb Exp Pharmacol       Date:  2012

Review 9.  Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion?

Authors:  Hsiao-Huei Chen; Naif A M Almontashiri; Darlène Antoine; Alexandre F R Stewart
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

10.  Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and myocardial infarction risk.

Authors:  Meng Fan; Sonny Dandona; Ruth McPherson; Hooman Allayee; Stanley L Hazen; George A Wells; Robert Roberts; Alexandre F R Stewart
Journal:  Circ Cardiovasc Genet       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.